fda approves first oral glp-1 obesity drug august 21 2025 Orforglipron, approved as Foundayo on April 1, 2026, adds another option for chronic weight management in adults with or overweight plus at least one weight-related condition. The clinical relevance A Pill to Fight Obesity

Marketing a service before you've built the infrastructure puts both patients and your clinic at risk

Further studies are needed to gain a deeper understanding of mechanisms and impact on long-term survival

Sugary drinks, white bread, pastries, fried fast food, and processed snacks tend to spike blood sugar and insulin, which encourages fat to be stored around your organs

However, since children may swallow bath water or put their creamed hands in their mouths, gluten in body care products can also become a problem for them

Which One Is Right for You The answer depends on your current fitness level, your tolerance for stimulants, your health status, and your specific goal within the broader weight-loss objective